Mein Warenkorb

CD98

CD98 Molekülinformation

Englischer NameL-type amino acid transporter 1Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel6Target-AliasD16S469E,Solute Carrier Family 7 (Cationic Amino Acid Transporter, Y+ System), Member 5,LAT1,SLC7A5,Y+ System Cationic Amino Acid Transporter,4F2LC,4F2 LC,Large Neutral Amino Acid-Transporter 1,Large Neutral Amino Acids Transporter Small Subunit 1,Solute Carrier Family 7 Member 5,HLAT1,CD98LC,CD98,Sodium-Independent Neutral Amino Acid Transporter LAT1,L-Type Amino Acid Transporter 1,4F2 Light Chain,E16,Solute Carrier Family 7 (Amino Acid Transporter Light Chain, L System), Member 5,MPE16,Integral Membrane Protein E16,CD98 Light Chain
Höchste Forschungs- und EntwicklungsphaseNDA/BLA
Englischer NameL-type amino acid transporter 1
Target-AliasD16S469E,Solute Carrier Family 7 (Cationic Amino Acid Transporter, Y+ System), Member 5,LAT1,SLC7A5,Y+ System Cationic Amino Acid Transporter,4F2LC,4F2 LC,Large Neutral Amino Acid-Transporter 1,Large Neutral Amino Acids Transporter Small Subunit 1,Solute Carrier Family 7 Member 5,HLAT1,CD98LC,CD98,Sodium-Independent Neutral Amino Acid Transporter LAT1,L-Type Amino Acid Transporter 1,4F2 Light Chain,E16,Solute Carrier Family 7 (Amino Acid Transporter Light Chain, L System), Member 5,MPE16,Integral Membrane Protein E16,CD98 Light Chain
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel6
Höchste Forschungs- und EntwicklungsphaseNDA/BLA

CD98 Molekülhintergrund

CD antigen CD98 is also known as 4F2 cell-surface antigen heavy chain (4F2hc), 4F2 heavy chain antigen, Solute carrier family 3 member 2 (SLC3A2), Lymphocyte activation antigen 4F2 large subunit, is a single-pass type I I membrane protein which belongs to the SLC3A transporter family.. SLC3A2 / CD98 is expressed ubiquitously in all tissues tested with highest levels detected in kidney, placenta and testis and weakest level in thymus. SLC3A2 / CD98 is required for the function of light chain amino-acid transporters and also involved in sodium-independent, high-affinity transport of large neutral amino acids such as phenylalanine, tyrosine, leucine, arginine and tryptophan. CD98 involved in guiding and targeting of LAT1 and LAT2 to the plasma membrane. When associated with SLC7A5 or SLC7A8, CD98 involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane. Together with ICAM1, regulates the transport activity LAT2 in polarized intestinal cells, by generating and delivering intracellular signals.

CD98 Molekülalias

SLC3A2,CD98,4F2,4F2HC,4T2HC,CD98HC,MDU1,NACAE

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
R-OKY-034FR-OKY-034FPhase 2 ClinicalOsaka University, Japan Agency For Medical Research And DevelopmentPancreatic Neoplasms
Details
NanvuranlatJPH-203SBECD; JPH-203; KYT-0353Phase 2 ClinicalJ-PharmaBiliary Tract Neoplasms
Details
[18F]BF3-BPA[18F]BF3-BPA; BR-02Phase 2 ClinicalBoomRay Pharmaceuticals Co LtdNeoplasms; Brain Neoplasms; Brain contrast agents
Details
QBS-10072-SQBS-10072-S; QBS72S; QBS-72-S; QBS'72S; NBQ-72S; QBS10072SPhase 2 ClinicalQuadriga Biosciences IncBrain Neoplasms; Melanoma; Tongue Neoplasms; Uterine Cervical Neoplasms; Thymoma; Lung Neoplasms; Brain metastases; Colorectal Neoplasms; Astrocytoma; Urologic Neoplasms; Meningeal Neoplasms; Prostatic Neoplasms; Sarcoma; Kidney Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Urinary Bladder Neoplasms; Mesothelioma; Pancreatic Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Head and Neck Neoplasms; Liver Neoplasms; Ovarian Neoplasms; Solid tumours
Details
131I-ACD-101TLX101; TLX-101; 131I-ACD-101; 131I-IPA; 131I-TX-101Phase 2 ClinicalTelix Pharmaceuticals LtdGlioblastoma; Neoplasms; Breast Neoplasms
Details
[18F]AA-7[18F]AA-7ClinicalOsaka City University, Institute Physical Chemical Research (Riken), Nagase MedicalsGlioma
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns